Get startedLog in
    Picture of Zealand Pharma A/S logo

    ZEAL — Zealand Pharma A/S News Story

    0.000.00%
    dk flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMid CapNeutral
    All News

    Brief: Zealand Pharma Announces Positive Phase 2 Results For Petrelintide

    Picture of Zealand Pharma A/S logoZealand Pharma A/S
    05/03/2026 18:45
    March 5 (Reuters) - Zealand Pharma A/S ZELA.CO:

ZEALAND PHARMA ANNOUNCES POSITIVE PHASE 2 RESULTS FOR PETRELINTIDE, AN AMYLIN ANALOG WITH POTENTIAL TO REDEFINE THE WEIGHT MANAGEMENT EXPERIENCE FOR PEOPLE LIVING WITH OVERWEIGHT AND OBESITY

ZEALAND PHARMA - PHASE 2 TRIAL MEETS PRIMARY ENDPOINT WITH SIGNIFICANT WEIGHT REDUCTION AT 28 WEEKS

ZEALAND PHARMA: NO UNEXPECTED SAFETY SIGNALS WERE OBSERVED WITH PETRELINTIDE TREATMENT

Source text: ID:nGNX6swBBY

Further company coverage: ZELA.CO

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Zealand Pharma A/S

    See all news